Skip to main content
. 2018 Dec 20;13:37–46. doi: 10.2147/PPA.S185848

Table 3.

Baseline Medicare Advantage Plan participant and medication characteristicsa

n (%) Not adherent at final, n (%) Adherent at final, n (%) P-value

Language of letter 0.216b
 English 362 (78.7) 270 (74.6) 92 (25.4)
 Spanish 98 (21.3) 79 (80.6) 19 (19.4)
Age 0.676c
 Age, years 70.0±10.5 70.1±10.7 69.6±9.9
Gender 0.784b
 Female 231 (50.2) 174 (75.3) 57 (24.7)
 Male 229 (49.8) 175 (76.4) 54 (23.6)
Ethnicity 0.602b
 White 307 (66.7) 232 (75.6) 75 (24.4)
 Hispanic 66 (14.4) 54 (81.8) 12 (18.2)
 African-American 80 (17.4) 58 (72.5) 22 (27.5)
 Asian 7 (1.5) 5 (71.4) 2 (28.6)
Region 0.576b
 Out of Texas 16 (3.5) 13 (81.3) 3 (18.8)
 West Texas 221 (48.1) 171 (77.4) 50 (22.6)
 East Texas 223 (48.5) 165 (74.0) 58 (26.0)
Low Income subsidy eligibility 0.575b
 No 222 (48.3) 171 (77.0) 51 (23.0)
 Yes 238 (51.7) 178 (74.8) 60 (25.2)
Medication category 0.223b
 Statin 196 (42.6) 141 (71.9) 55 (28.1)
 ACEI/ARB 189 (41.1) 150 (79.4) 39 (20.6)
 Oral antidiabetic 75 (16.3) 58 (77.3) 17 (22.7)
Generic vs brand 0.655b
 Generic 431 (93.7) 326 (75.6) 105 (24.4)
 Brand 29 (6.3) 23 (79.3) 6 (20.7)
Day supply 0.013b
 30 days or less 170 (37.0) 140 (82.4) 30 (17.7)
 >30 days 290 (63.0) 209 (72.1) 81 (27.9)
Copay 0.782c
 Copay, $ 4.36±12.64 4.45±13.41 4.07±9.89
Pharmacy type 0.805b
 Retail 449 (97.6) 341 (76.0) 108 (24.1)
 Mail order 11 (2.4) 8 (72.7) 3 (27.3)
Initial PDC 0.013c
 PDC 0.51±0.11 0.51±0.12 0.54±0.09

Notes:

a

Values represent mean ± SD for age, copay, and initial PDC.

b

Chi-squared test.

c

t-Test.

Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; PDC, proportion of days covered.